首页 > 最新文献

BMC Surgery最新文献

英文 中文
The application of interventional methods in control of blood loss during giant upper extremity tumor resection. 应用介入方法控制巨大上肢肿瘤切除术中的失血量。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-11-02 DOI: 10.1186/s12893-024-02643-5
Fei Huo, Hansheng Liang, Yi Feng

Background: The purposes of this retrospective study were to determine the efficacy of interventional methods in control of intraoperative blood losses and investigate the perioperative complications.

Methods: The cases of 44 patients in whom a giant upper extremity tumor had been operated between 2008 and 2022 were analyzed retrospectively. Of these, 29 patients were treated with interventional methods (Group A) and 15 were treated without (Group B). Group A was further divided based on the intervention methodss: Group C (combination of balloon occlusion and transarterial embolization [TAE], n = 11) and Group D (single TAE, n = 18). Within Group D, patients were categorized based on the timing of TAE relative to surgery into Group E (TAE on the same day as surgery) and Group F (TAE performed days before surgery). We compared demographic features, blood loss, ICU admission rates, and use of vasopressors during surgery.

Results: We collected clinical records from 44 patients diagnosed with a giant upper extremity tumor who underwent surgery. Group sizes were as follows: A (29), B (15), C (11), D (18), E (7), and F (11). Tumor volumes in the interventional and non-interventional groups were similar (704.19 ± 812.77 cm³ vs. 1224.53 ± 1414.01 cm³, P = 0.127). Blood plasma transfusion was significantly higher in Group B compared to Group A (425.33 ± 476.20 ml vs. 155.90 ± 269.67 ml, P = 0.021). Although overall blood loss did not significantly differ between Group A and Group B (467.93 ± 302.08 ml vs. 1150 ± 1424.15 ml, P = 0.087), the rate of massive bleeding (defined as blood loss over 1000 ml) was lower in Group A (6.9% vs. 46.47%, P = 0.004). The proportion of minors (patients aged less than 18) in Group C was significantly higher than in Group D (27.7% vs. 0.00%, P = 0.045). The amount of RBC transfusion was also significantly higher in Group C compared to Group D (458.18 ± 292.22 ml vs. 164.44 ± 224.03 ml, P = 0.021). No significant perioperative complications were observed.

Conclusions: Interventional techniques have been shown to reduce both blood loss and the necessity for blood transfusions in patients with large upper extremity tumors. Furthermore, no significant perioperative complications have been observed.

背景:这项回顾性研究的目的是确定介入方法在控制术中失血方面的效果,并调查围手术期并发症:这项回顾性研究旨在确定介入方法在控制术中失血量方面的疗效,并调查围手术期并发症:方法:回顾性分析了 2008 年至 2022 年间接受手术治疗的 44 例巨大上肢肿瘤患者。其中,29 名患者接受了介入治疗(A 组),15 名患者未接受介入治疗(B 组)。根据介入方法的不同,A 组又被进一步划分:C组(联合球囊闭塞和经动脉栓塞[TAE],n = 11)和D组(单一TAE,n = 18)。在 D 组中,根据 TAE 相对于手术的时间将患者分为 E 组(TAE 与手术在同一天进行)和 F 组(TAE 在手术前几天进行)。我们比较了人口统计学特征、失血量、重症监护室入院率和手术中使用血管加压药的情况:我们收集了 44 名确诊为上肢巨大肿瘤并接受手术的患者的临床记录。分组情况如下A组(29人)、B组(15人)、C组(11人)、D组(18人)、E组(7人)和F组(11人)。介入组和非介入组的肿瘤体积相似(704.19 ± 812.77 cm³ vs. 1224.53 ± 1414.01 cm³, P = 0.127)。B 组的血浆输注量明显高于 A 组(425.33 ± 476.20 ml vs. 155.90 ± 269.67 ml,P = 0.021)。虽然 A 组和 B 组的总失血量没有明显差异(467.93 ± 302.08 毫升 vs 1150 ± 1424.15 毫升,P = 0.087),但 A 组的大量出血率(定义为失血超过 1000 毫升)较低(6.9% vs 46.47%,P = 0.004)。C 组未成年人(18 岁以下患者)的比例明显高于 D 组(27.7% 对 0.00%,P = 0.045)。C 组的红细胞输注量也明显高于 D 组(458.18 ± 292.22 ml vs. 164.44 ± 224.03 ml,P = 0.021)。没有观察到明显的围手术期并发症:结论:介入技术可减少上肢大肿瘤患者的失血量和输血必要性。此外,未观察到明显的围手术期并发症。
{"title":"The application of interventional methods in control of blood loss during giant upper extremity tumor resection.","authors":"Fei Huo, Hansheng Liang, Yi Feng","doi":"10.1186/s12893-024-02643-5","DOIUrl":"10.1186/s12893-024-02643-5","url":null,"abstract":"<p><strong>Background: </strong>The purposes of this retrospective study were to determine the efficacy of interventional methods in control of intraoperative blood losses and investigate the perioperative complications.</p><p><strong>Methods: </strong>The cases of 44 patients in whom a giant upper extremity tumor had been operated between 2008 and 2022 were analyzed retrospectively. Of these, 29 patients were treated with interventional methods (Group A) and 15 were treated without (Group B). Group A was further divided based on the intervention methodss: Group C (combination of balloon occlusion and transarterial embolization [TAE], n = 11) and Group D (single TAE, n = 18). Within Group D, patients were categorized based on the timing of TAE relative to surgery into Group E (TAE on the same day as surgery) and Group F (TAE performed days before surgery). We compared demographic features, blood loss, ICU admission rates, and use of vasopressors during surgery.</p><p><strong>Results: </strong>We collected clinical records from 44 patients diagnosed with a giant upper extremity tumor who underwent surgery. Group sizes were as follows: A (29), B (15), C (11), D (18), E (7), and F (11). Tumor volumes in the interventional and non-interventional groups were similar (704.19 ± 812.77 cm³ vs. 1224.53 ± 1414.01 cm³, P = 0.127). Blood plasma transfusion was significantly higher in Group B compared to Group A (425.33 ± 476.20 ml vs. 155.90 ± 269.67 ml, P = 0.021). Although overall blood loss did not significantly differ between Group A and Group B (467.93 ± 302.08 ml vs. 1150 ± 1424.15 ml, P = 0.087), the rate of massive bleeding (defined as blood loss over 1000 ml) was lower in Group A (6.9% vs. 46.47%, P = 0.004). The proportion of minors (patients aged less than 18) in Group C was significantly higher than in Group D (27.7% vs. 0.00%, P = 0.045). The amount of RBC transfusion was also significantly higher in Group C compared to Group D (458.18 ± 292.22 ml vs. 164.44 ± 224.03 ml, P = 0.021). No significant perioperative complications were observed.</p><p><strong>Conclusions: </strong>Interventional techniques have been shown to reduce both blood loss and the necessity for blood transfusions in patients with large upper extremity tumors. Furthermore, no significant perioperative complications have been observed.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"343"},"PeriodicalIF":1.6,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11531193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
99mTc-GSA scintigraphy and modified albumin-bilirubin score can be complementary to ICG for predicting posthepatectomy liver failure. 在预测肝切除术后肝功能衰竭方面,99m锝-GSA闪烁扫描和改良白蛋白-胆红素评分可与ICG互为补充。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-11-01 DOI: 10.1186/s12893-024-02624-8
Satoshi Mii, Takeshi Takahara, Susumu Shibasaki, Takuma Ishihara, Takuya Mizumoto, Yuichiro Uchida, Hideaki Iwama, Masayuki Kojima, Yutaro Kato, Koichi Suda

Background: Posthepatectomy liver failure (PHLF) remains a severe complication after liver resection. This retrospective study investigated the correlation of three hepatic functional tests and whether 99mTc-galactosyl human serum albumin (99mTc-GSA) scintigraphy and modified albumin-bilirubin (ALBI) score are useful for predicting PHLF.

Methods: This retrospective cohort study included 413 consecutive patients undergoing hepatectomies between January 2017 and December 2020. To evaluate preoperative hepatic functional reserve, modified ALBI grade, indocyanine green clearance (ICG-R15), and 99mTc-GSA scintigraphy (LHL15) were examined before scheduled hepatectomy. Based on a retrospective chart review, multivariable logistic regression analysis adjusted for confounding factors was performed to confirm that mALBI, ICG-R15, and LHL15 are independent risk factors for PHLF.

Results: ICG-R15 and LHL15 were moderately correlated (r =  - 0.61) but this correlation weakened when ICG-R15 was about ≥ 20. Weak correlations were observed between LHL15 and ALBI score (r =  - 0.269) and ALBI score and ICG-R15 (r = 0.339). Of 413 patients, 66 (19%) developed PHLF (20 grade A, 44 grade B, 2 grade C). Multivariable logistic regression analyses, major hepatectomy (P < 0.001), mALBI grade (P = 0.01), ICG-R15 (P < 0.001), and Esophagogastric varices (P = 0.007) were significant independent risk factors for PHLF. Subgroup analysis showed that ICG-R15 < 19, major hepatectomy, and mALBI grade and ICG-R15 ≥ 19, major hepatectomy, LHL15, and Esophagogastric varices were significant independent risk factors for PHLF (P = 0.033, 0.017, 0.02, 0.02, and 0.001, respectively).

Conclusion: LHL15, the assessment of Esophagogastric varices, and mALBI grade are complementary to ICG-R15 for predicting PHLF risk.

背景:肝切除术后肝衰竭(PHLF肝切除术后肝功能衰竭(PHLF)仍是肝切除术后的一种严重并发症。这项回顾性研究调查了三种肝功能检测的相关性,以及99m锝-半乳糖基人血清白蛋白(99m锝-GSA)闪烁扫描和改良白蛋白-胆红素(ALBI)评分是否有助于预测PHLF:这项回顾性队列研究纳入了2017年1月至2020年12月期间接受肝切除术的413例连续患者。为评估术前肝功能储备,在预定的肝切除术前检查了改良的ALBI分级、吲哚青绿清除率(ICG-R15)和99m锝-GSA闪烁成像(LHL15)。在回顾性病历审查的基础上,对混杂因素进行了多变量逻辑回归分析,以证实mALBI、ICG-R15和LHL15是PHLF的独立风险因素:ICG-R15和LHL15呈中度相关(r = - 0.61),但当ICG-R15约≥20时,这种相关性减弱。在 LHL15 和 ALBI 评分(r = - 0.269)以及 ALBI 评分和 ICG-R15 (r = 0.339)之间观察到较弱的相关性。在 413 例患者中,66 例(19%)发展为 PHLF(20 例 A 级,44 例 B 级,2 例 C 级)。多变量逻辑回归分析、肝大部切除术(P 结论:肝大部切除术是一种有效的肝脏切除术:LHL15、食管胃静脉曲张评估和 mALBI 分级是 ICG-R15 预测 PHLF 风险的补充。
{"title":"99mTc-GSA scintigraphy and modified albumin-bilirubin score can be complementary to ICG for predicting posthepatectomy liver failure.","authors":"Satoshi Mii, Takeshi Takahara, Susumu Shibasaki, Takuma Ishihara, Takuya Mizumoto, Yuichiro Uchida, Hideaki Iwama, Masayuki Kojima, Yutaro Kato, Koichi Suda","doi":"10.1186/s12893-024-02624-8","DOIUrl":"10.1186/s12893-024-02624-8","url":null,"abstract":"<p><strong>Background: </strong>Posthepatectomy liver failure (PHLF) remains a severe complication after liver resection. This retrospective study investigated the correlation of three hepatic functional tests and whether 99mTc-galactosyl human serum albumin (99mTc-GSA) scintigraphy and modified albumin-bilirubin (ALBI) score are useful for predicting PHLF.</p><p><strong>Methods: </strong>This retrospective cohort study included 413 consecutive patients undergoing hepatectomies between January 2017 and December 2020. To evaluate preoperative hepatic functional reserve, modified ALBI grade, indocyanine green clearance (ICG-R15), and 99mTc-GSA scintigraphy (LHL15) were examined before scheduled hepatectomy. Based on a retrospective chart review, multivariable logistic regression analysis adjusted for confounding factors was performed to confirm that mALBI, ICG-R15, and LHL15 are independent risk factors for PHLF.</p><p><strong>Results: </strong>ICG-R15 and LHL15 were moderately correlated (r =  - 0.61) but this correlation weakened when ICG-R15 was about ≥ 20. Weak correlations were observed between LHL15 and ALBI score (r =  - 0.269) and ALBI score and ICG-R15 (r = 0.339). Of 413 patients, 66 (19%) developed PHLF (20 grade A, 44 grade B, 2 grade C). Multivariable logistic regression analyses, major hepatectomy (P < 0.001), mALBI grade (P = 0.01), ICG-R15 (P < 0.001), and Esophagogastric varices (P = 0.007) were significant independent risk factors for PHLF. Subgroup analysis showed that ICG-R15 < 19, major hepatectomy, and mALBI grade and ICG-R15 ≥ 19, major hepatectomy, LHL15, and Esophagogastric varices were significant independent risk factors for PHLF (P = 0.033, 0.017, 0.02, 0.02, and 0.001, respectively).</p><p><strong>Conclusion: </strong>LHL15, the assessment of Esophagogastric varices, and mALBI grade are complementary to ICG-R15 for predicting PHLF risk.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"342"},"PeriodicalIF":1.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11529431/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma. 肝细胞癌治愈性切除术后早期和多次复发的预后意义。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-29 DOI: 10.1186/s12893-024-02642-6
Akihiro Tanemura, Daisuke Noguchi, Toru Shinkai, Takahiro Ito, Aoi Hayasaki, Kazuyuki Gyoten, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Naohisa Kuriyama, Masashi Kishiwada, Shugo Mizuno

Background: In hepatocellular carcinoma (HCC), postoperative recurrence remains high. This study aimed to evaluate the recurrence patterns and prognosis of HCC after curative hepatectomy.

Methods: Among 352 patients with primary HCC who underwent initial hepatectomy between January 2002 and December 2022, 151 with recurrence were assessed for the relationship between recurrence pattern and prognosis.

Results: The early recurrence group (within 6 months postoperatively; n = 38) had significantly higher serum alpha-fetoprotein (p = 0.002), des-γ-carboxyprothrombin (DCP; p = 0.004) levels and Barcelona Clinic Liver Cancer (BCLC) stage (p < 0.001), larger tumor size (p < 0.001), higher incidence of multiple tumors (p = 0.002) and lower overall survival (OS) (p < 0.001) than the late recurrence group (> 6 months postoperatively; n = 113). The tumor size (p = 0.013) and BCLC stage (p = 0.001) were independent risk factors for early recurrence within 6 months in multivariate analysis. The multiple recurrence group (intrahepatic multinodular recurrence or distant metastasis; n = 89) had significantly lower prognostic nutritional index (p = 0.026), larger tumor size (p = 0.017), lower incidence of liver cirrhosis (p = 0.03) than the single recurrence group (single nodule recurrence; n = 62). The multiple recurrence group, especially patients with ≥ three intrahepatic nodules and distant metastases, had lower postoperative OS (p < 0.001) and shorter time to recurrence (p < 0.001) than the single recurrence group. When the patients were classified into three groups: late recurrence with one or two tumors (Group A; n = 74), early recurrence or three or more tumors or distant metastasis (Group B; n = 54), and early recurrence with three or more tumors or distant metastasis (Group C; n = 23), OS was significantly lower in Groups B and C than Group A (p < 0.001).

Conclusions: Patients with early recurrence within 6 months after surgery and three or more recurrence nodule or distant metastasis exhibited poor prognosis after initial recurrence, and they should be carefully followed up.

背景:肝细胞癌(HCC)术后复发率居高不下。本研究旨在评估肝癌根治性切除术后的复发模式和预后:方法:在2002年1月至2022年12月期间接受初次肝切除术的352例原发性HCC患者中,对151例复发患者的复发模式与预后之间的关系进行评估:结果:早期复发组(术后6个月内;n = 38)的血清甲胎蛋白(p = 0.002)、去γ-羧基凝血酶原(DCP;p = 0.004)水平和巴塞罗那临床肝癌(BCLC)分期(术后6个月内;n = 113)均显著升高。在多变量分析中,肿瘤大小(p = 0.013)和 BCLC 分期(p = 0.001)是 6 个月内早期复发的独立危险因素。多发复发组(肝内多结节复发或远处转移;n = 89)的预后营养指数(p = 0.026)、肿瘤大小(p = 0.017)、肝硬化发生率(p = 0.03)均显著低于单发复发组(单结节复发;n = 62)。多发复发组,尤其是肝内结节≥3个且有远处转移的患者,术后OS较低(p 结论:多发复发组术后OS低于单发复发组(p = 0.017):术后 6 个月内早期复发且有三个或三个以上复发结节或远处转移的患者初次复发后预后较差,应仔细随访。
{"title":"Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma.","authors":"Akihiro Tanemura, Daisuke Noguchi, Toru Shinkai, Takahiro Ito, Aoi Hayasaki, Kazuyuki Gyoten, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Naohisa Kuriyama, Masashi Kishiwada, Shugo Mizuno","doi":"10.1186/s12893-024-02642-6","DOIUrl":"10.1186/s12893-024-02642-6","url":null,"abstract":"<p><strong>Background: </strong>In hepatocellular carcinoma (HCC), postoperative recurrence remains high. This study aimed to evaluate the recurrence patterns and prognosis of HCC after curative hepatectomy.</p><p><strong>Methods: </strong>Among 352 patients with primary HCC who underwent initial hepatectomy between January 2002 and December 2022, 151 with recurrence were assessed for the relationship between recurrence pattern and prognosis.</p><p><strong>Results: </strong>The early recurrence group (within 6 months postoperatively; n = 38) had significantly higher serum alpha-fetoprotein (p = 0.002), des-γ-carboxyprothrombin (DCP; p = 0.004) levels and Barcelona Clinic Liver Cancer (BCLC) stage (p < 0.001), larger tumor size (p < 0.001), higher incidence of multiple tumors (p = 0.002) and lower overall survival (OS) (p < 0.001) than the late recurrence group (> 6 months postoperatively; n = 113). The tumor size (p = 0.013) and BCLC stage (p = 0.001) were independent risk factors for early recurrence within 6 months in multivariate analysis. The multiple recurrence group (intrahepatic multinodular recurrence or distant metastasis; n = 89) had significantly lower prognostic nutritional index (p = 0.026), larger tumor size (p = 0.017), lower incidence of liver cirrhosis (p = 0.03) than the single recurrence group (single nodule recurrence; n = 62). The multiple recurrence group, especially patients with ≥ three intrahepatic nodules and distant metastases, had lower postoperative OS (p < 0.001) and shorter time to recurrence (p < 0.001) than the single recurrence group. When the patients were classified into three groups: late recurrence with one or two tumors (Group A; n = 74), early recurrence or three or more tumors or distant metastasis (Group B; n = 54), and early recurrence with three or more tumors or distant metastasis (Group C; n = 23), OS was significantly lower in Groups B and C than Group A (p < 0.001).</p><p><strong>Conclusions: </strong>Patients with early recurrence within 6 months after surgery and three or more recurrence nodule or distant metastasis exhibited poor prognosis after initial recurrence, and they should be carefully followed up.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"339"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of 4.54% hypertonic saline and 20% mannitol for brain relaxation during auditory brainstem implantation in pediatric patients: a single-center retrospective observational cohort study. 比较 4.54% 高渗盐水和 20% 甘露醇在儿科患者听性脑干植入术中的脑松弛作用:一项单中心回顾性观察队列研究。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-29 DOI: 10.1186/s12893-024-02639-1
Hao Fan, Linhong Zhong, Huan Jia, Jinya Shi, Jingjie Li

Background: Mannitol is frequently utilized to achieve intracranial brain relaxation during the retrosigmoid approach for auditory brainstem implantation (ABI). Hypertonic saline (HS) is an alternative for reducing intracranial pressure; however, its application during ABI surgery remains under-investigated. We aimed to compare the efficacy and safety between HS and mannitol for maintaining brain relaxation.

Methods: This single-center retrospective cohort study included pediatric patients undergoing ABI surgery from September 2020 to January 2022 who received only 4.54% HS or 20% mannitol for brain relaxation. The analysis involved initial doses, subsequent doses, and dosing intervals of the two hyperosmolar solutions, as well as the time elapsed from meningeal opening to the first ABI electrode placement attempt. Additionally, the analysis encompassed electrolyte testing, hemodynamic variables, urine output, blood transfusion, second surgeries, adverse events, intensive care unit length of stay, and 30-day mortality.

Results: We analyzed 68 consecutive pediatric patients; 26 and 42 in the HS and mannitol groups, respectively. The HS group exhibited a reduced rate of supplementary use (7.7% vs. 31%) and lower total urine volume. Perioperative outcomes, mortality, and length of intensive care unit stay did not exhibit significant between-group differences, despite transient increases in blood sodium and chloride observed within 2 h after HS infusion.

Conclusions: In pediatric ABI surgery, as an osmotherapy for cerebral relaxation, 4.54% HS demonstrated a lower likelihood of necessitating additional supplementation than 20% mannitol. Furthermore, the diuretic effect of HS was weak and the increase in electrolyte levels during surgery was temporary and slight.

背景:在进行听性脑干植入术(ABI)时,经常使用甘露醇来实现颅内脑松弛。高渗盐水(HS)是降低颅内压的一种替代方法,但其在 ABI 手术中的应用仍未得到充分研究。我们旨在比较 HS 和甘露醇在维持脑松弛方面的有效性和安全性:这项单中心回顾性队列研究纳入了 2020 年 9 月至 2022 年 1 月期间接受 ABI 手术的儿科患者,这些患者仅接受了 4.54% HS 或 20% 甘露醇进行脑松弛。分析涉及两种高渗溶液的初始剂量、后续剂量和给药间隔,以及从脑膜开放到首次尝试 ABI 电极置入的时间。此外,分析还包括电解质检测、血液动力学变量、尿量、输血、二次手术、不良事件、重症监护室住院时间和 30 天死亡率:我们对 68 名连续的儿科患者进行了分析,其中 HS 组和甘露醇组分别有 26 人和 42 人。HS组的辅助用药率较低(7.7% 对 31%),总尿量较少。尽管在输注 HS 后 2 小时内观察到血钠和血氯短暂升高,但围手术期结果、死亡率和重症监护室住院时间在组间并无显著差异:结论:在小儿 ABI 手术中,4.54% 的 HS 可作为脑松弛的渗透疗法,与 20% 的甘露醇相比,需要额外补充的可能性更低。此外,HS 的利尿作用较弱,手术过程中电解质水平的升高是暂时和轻微的。
{"title":"Comparison of 4.54% hypertonic saline and 20% mannitol for brain relaxation during auditory brainstem implantation in pediatric patients: a single-center retrospective observational cohort study.","authors":"Hao Fan, Linhong Zhong, Huan Jia, Jinya Shi, Jingjie Li","doi":"10.1186/s12893-024-02639-1","DOIUrl":"10.1186/s12893-024-02639-1","url":null,"abstract":"<p><strong>Background: </strong>Mannitol is frequently utilized to achieve intracranial brain relaxation during the retrosigmoid approach for auditory brainstem implantation (ABI). Hypertonic saline (HS) is an alternative for reducing intracranial pressure; however, its application during ABI surgery remains under-investigated. We aimed to compare the efficacy and safety between HS and mannitol for maintaining brain relaxation.</p><p><strong>Methods: </strong>This single-center retrospective cohort study included pediatric patients undergoing ABI surgery from September 2020 to January 2022 who received only 4.54% HS or 20% mannitol for brain relaxation. The analysis involved initial doses, subsequent doses, and dosing intervals of the two hyperosmolar solutions, as well as the time elapsed from meningeal opening to the first ABI electrode placement attempt. Additionally, the analysis encompassed electrolyte testing, hemodynamic variables, urine output, blood transfusion, second surgeries, adverse events, intensive care unit length of stay, and 30-day mortality.</p><p><strong>Results: </strong>We analyzed 68 consecutive pediatric patients; 26 and 42 in the HS and mannitol groups, respectively. The HS group exhibited a reduced rate of supplementary use (7.7% vs. 31%) and lower total urine volume. Perioperative outcomes, mortality, and length of intensive care unit stay did not exhibit significant between-group differences, despite transient increases in blood sodium and chloride observed within 2 h after HS infusion.</p><p><strong>Conclusions: </strong>In pediatric ABI surgery, as an osmotherapy for cerebral relaxation, 4.54% HS demonstrated a lower likelihood of necessitating additional supplementation than 20% mannitol. Furthermore, the diuretic effect of HS was weak and the increase in electrolyte levels during surgery was temporary and slight.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"340"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520520/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of multimodal opioid-sparing anesthesia on intestinal function and prognosis of elderly patients with hypertension after colorectal cancer surgery. 多模式阿片保留麻醉对老年高血压患者结直肠癌手术后肠道功能和预后的影响
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-29 DOI: 10.1186/s12893-024-02604-y
Yan-Kai Ma, Li Qu, Nan Chen, Zhe Chen, Yin Li, A Li Mu Jiang, Alimujiang Ismayi, Xiao-Liang Zhao, Gui-Ping Xu

Purpose: Colorectal cancer (CRC) surgery in elderly patients with hypertension poses challenges due to potential complications and prolonged recovery. This study aimed to assess the impact of multimodal opioid-sparing anesthesia on intestinal function and prognosis of elderly hypertension patients undergoing CRC surgery.

Methods: A total of 80 elderly hypertension patients who underwent open surgery for CRC in the People's Hospital of Xinjiang Uygur Autonomous Region from October 2020 to October 2022 were selected and randomly divided into two group (A and B, n = 40) through the random number table method. Group A received multimodal opioid-sparing anesthesia, defined as low-dose opioid general anesthesia combined with a transversus abdominis plane block, incision infiltration with local anesthetics, and postoperative analgesia via a patient-controlled analgesia (PCA) pump, with the remifentanil dose set at one-third (± 10%) of the conventional group's dose. Group B received conventional opioid anesthesia, involving standard general anesthesia maintained with remifentanil at 0.4-0.5 µg/(kg·min), incision infiltration with local anesthetics, and postoperative PCA. Primary outcomes included mean arterial pressure (MAP) and heart rate (HR), changes in albumin, C-reactive protein (CRP) and white blood cell (WBC), indicators of intestinal function recovery (the recovery time of bowel sounds, the first exhaust time, the first defecation time and the feeding recovery time), and visual analogue scale (VAS) pain scores. Second outcomes included postoperative complications and total hospital stays.

Results: After excluding 8 patients, 72 were included in the final analysis. Compared with patients in the B group, patients in the A group exhibited shorter recovery time of bowel sounds, first exhaust time and feeding recovery time (P < 0.05), higher levels of postoperative albumin, and lower levels of CRP and WBC (P < 0.05). Moreover, the incidence of nausea and vomiting was lower and the total hospital stays were fewer in the A group than in the B group (P < 0.05).

Conclusion: Multimodal opioid-sparing anesthesia contributes to rapid recovery of postoperative intestinal function and reduction of postoperative adverse reactions. Therefore, it is safe and feasible to apply multimodal opioid-sparing anesthesia to elderly hypertension patients receiving open surgery for CRC.

目的:老年高血压患者接受结直肠癌(CRC)手术会面临潜在并发症和恢复期延长的挑战。本研究旨在评估多模式阿片类药物稀释麻醉对接受 CRC 手术的老年高血压患者肠道功能和预后的影响:方法:选取2020年10月至2022年10月在新疆维吾尔自治区人民医院接受CRC开腹手术的老年高血压患者共80例,通过随机数字表法随机分为两组(A组和B组,n=40)。A组接受多模式阿片类药物稀释麻醉,即低剂量阿片类药物全身麻醉联合腹横肌平面阻滞、切口局麻药浸润、术后患者自控镇痛(PCA)泵镇痛,瑞芬太尼剂量为常规组的三分之一(±10%)。B 组接受常规阿片类麻醉,包括使用 0.4-0.5 µg/(kg-min) 的瑞芬太尼维持标准全身麻醉、局部麻醉剂切口浸润和术后 PCA。主要结果包括平均动脉压(MAP)和心率(HR)、白蛋白、C反应蛋白(CRP)和白细胞(WBC)的变化、肠道功能恢复指标(肠鸣音恢复时间、首次排气时间、首次排便时间和进食恢复时间)以及视觉模拟量表(VAS)疼痛评分。第二项结果包括术后并发症和总住院时间:结果:在排除 8 名患者后,72 名患者被纳入最终分析。与 B 组患者相比,A 组患者的肠鸣音恢复时间、首次排气时间和进食恢复时间较短(P多模式阿片类药物保留麻醉有助于术后肠道功能的快速恢复并减少术后不良反应。因此,对接受 CRC 开放手术的老年高血压患者应用多模式阿片类药物稀释麻醉是安全可行的。
{"title":"Effect of multimodal opioid-sparing anesthesia on intestinal function and prognosis of elderly patients with hypertension after colorectal cancer surgery.","authors":"Yan-Kai Ma, Li Qu, Nan Chen, Zhe Chen, Yin Li, A Li Mu Jiang, Alimujiang Ismayi, Xiao-Liang Zhao, Gui-Ping Xu","doi":"10.1186/s12893-024-02604-y","DOIUrl":"10.1186/s12893-024-02604-y","url":null,"abstract":"<p><strong>Purpose: </strong>Colorectal cancer (CRC) surgery in elderly patients with hypertension poses challenges due to potential complications and prolonged recovery. This study aimed to assess the impact of multimodal opioid-sparing anesthesia on intestinal function and prognosis of elderly hypertension patients undergoing CRC surgery.</p><p><strong>Methods: </strong>A total of 80 elderly hypertension patients who underwent open surgery for CRC in the People's Hospital of Xinjiang Uygur Autonomous Region from October 2020 to October 2022 were selected and randomly divided into two group (A and B, n = 40) through the random number table method. Group A received multimodal opioid-sparing anesthesia, defined as low-dose opioid general anesthesia combined with a transversus abdominis plane block, incision infiltration with local anesthetics, and postoperative analgesia via a patient-controlled analgesia (PCA) pump, with the remifentanil dose set at one-third (± 10%) of the conventional group's dose. Group B received conventional opioid anesthesia, involving standard general anesthesia maintained with remifentanil at 0.4-0.5 µg/(kg·min), incision infiltration with local anesthetics, and postoperative PCA. Primary outcomes included mean arterial pressure (MAP) and heart rate (HR), changes in albumin, C-reactive protein (CRP) and white blood cell (WBC), indicators of intestinal function recovery (the recovery time of bowel sounds, the first exhaust time, the first defecation time and the feeding recovery time), and visual analogue scale (VAS) pain scores. Second outcomes included postoperative complications and total hospital stays.</p><p><strong>Results: </strong>After excluding 8 patients, 72 were included in the final analysis. Compared with patients in the B group, patients in the A group exhibited shorter recovery time of bowel sounds, first exhaust time and feeding recovery time (P < 0.05), higher levels of postoperative albumin, and lower levels of CRP and WBC (P < 0.05). Moreover, the incidence of nausea and vomiting was lower and the total hospital stays were fewer in the A group than in the B group (P < 0.05).</p><p><strong>Conclusion: </strong>Multimodal opioid-sparing anesthesia contributes to rapid recovery of postoperative intestinal function and reduction of postoperative adverse reactions. Therefore, it is safe and feasible to apply multimodal opioid-sparing anesthesia to elderly hypertension patients receiving open surgery for CRC.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"341"},"PeriodicalIF":1.6,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical implementation of minimally invasive esophagectomy. 微创食管切除术的临床实施。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-28 DOI: 10.1186/s12893-024-02641-7
Heinz Wykypiel, Philipp Gehwolf, Katrin Kienzl-Wagner, Valeria Wagner, Andreas Puecher, Thomas Schmid, Fergül Cakar-Beck, Aline Schäfer

Background: Minimally invasive surgery is becoming the method of choice for the resection of esophageal cancer worldwide.

Methods: Retrospective analysis of prospectively collected clinical data in a tertiary care center with a detailed description of the course of the program.

Results: A total of 136 transthoracic esophageal resections were performed between 2010 and 2023. The study group included 116 operations, 69 of which were fully minimally invasive and 47 hybrid. 80.0% of the study group underwent surgery using a multimodality approach. The median operation time was 431 min (± 103). The R0 resection rate was 100%. Forty-two patients (36.2%) had no postoperative complications. The postoperative Clavien-Dindo > IIIb morbidity was 27%. The postoperative 90-d mortality rate was 1.7%. The average number of lymph nodes removed in the last quarter of cancer patients was 31. The anastomotic insufficiency rate for reoperation was 4% (Ivor-Lewis 4.2%, McKeown 5%).

Conclusions: With extensive expertise in high-end minimally invasive abdominal and thoracic surgery, implementation of a minimally invasive esophageal resection program with a clinical and oncologic outcome within generally accepted limits is feasible.

背景:微创手术正成为全球食管癌切除术的首选方法:微创手术正成为全球食管癌切除术的首选方法:对一家三级医疗中心前瞻性收集的临床数据进行回顾性分析,并详细描述该计划的过程:2010年至2023年期间,共进行了136例经胸食管切除术。研究组包括 116 例手术,其中 69 例为全微创手术,47 例为混合手术。研究组中 80.0% 的手术采用了多模式方法。中位手术时间为431分钟(± 103)。R0切除率为100%。42名患者(36.2%)无术后并发症。术后 Clavien-Dindo > IIIb 级发病率为 27%。术后90天死亡率为1.7%。最后四分之一癌症患者切除的淋巴结平均数量为31个。再次手术的吻合口不全率为4%(Ivor-Lewis为4.2%,McKeown为5%):凭借在高端微创腹腔和胸腔手术方面的丰富经验,实施微创食管切除术是可行的,其临床和肿瘤结果也在普遍接受的范围内。
{"title":"Clinical implementation of minimally invasive esophagectomy.","authors":"Heinz Wykypiel, Philipp Gehwolf, Katrin Kienzl-Wagner, Valeria Wagner, Andreas Puecher, Thomas Schmid, Fergül Cakar-Beck, Aline Schäfer","doi":"10.1186/s12893-024-02641-7","DOIUrl":"10.1186/s12893-024-02641-7","url":null,"abstract":"<p><strong>Background: </strong>Minimally invasive surgery is becoming the method of choice for the resection of esophageal cancer worldwide.</p><p><strong>Methods: </strong>Retrospective analysis of prospectively collected clinical data in a tertiary care center with a detailed description of the course of the program.</p><p><strong>Results: </strong>A total of 136 transthoracic esophageal resections were performed between 2010 and 2023. The study group included 116 operations, 69 of which were fully minimally invasive and 47 hybrid. 80.0% of the study group underwent surgery using a multimodality approach. The median operation time was 431 min (± 103). The R0 resection rate was 100%. Forty-two patients (36.2%) had no postoperative complications. The postoperative Clavien-Dindo > IIIb morbidity was 27%. The postoperative 90-d mortality rate was 1.7%. The average number of lymph nodes removed in the last quarter of cancer patients was 31. The anastomotic insufficiency rate for reoperation was 4% (Ivor-Lewis 4.2%, McKeown 5%).</p><p><strong>Conclusions: </strong>With extensive expertise in high-end minimally invasive abdominal and thoracic surgery, implementation of a minimally invasive esophageal resection program with a clinical and oncologic outcome within generally accepted limits is feasible.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"337"},"PeriodicalIF":1.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) as predictors of postoperative delirium in patients undergoing off-pump coronary artery bypass grafting (OPCABG) with cerebral infarction. 全身免疫炎症指数(SII)和全身炎症反应指数(SIRI)是预测接受非体外循环冠状动脉旁路移植术(OPCABG)的脑梗塞患者术后谵妄的指标。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-28 DOI: 10.1186/s12893-024-02598-7
Bing-Sha Zhao, Wen-Qian Zhai, Min Ren, Zhao Zhang, Jian-Ge Han

Objective: Postoperative delirium (POD) is a common complication following off-pump coronary artery bypass grafting (OPCABG) and is associated with significant morbidity. This study aims to evaluate the correlation of systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) with postoperative delirium (POD) in patients with cerebral infarction undergoing OPCABG.

Methods: The perioperative cohort study included 321 patients who underwent OPCABG. Patients were divided into two groups based on the occurrence of POD: the delirium group (n = 113) and the non-delirium group (n = 208). Baseline characteristics, including gender, left ventricular ejection fraction (LVEF), surgery duration, hypertension, age, and smoking history were analyzed. SII and SIRI values were calculated preoperatively, and their association with POD was assessed using univariate and multivariate logistic regression analyses. Receiver operating characteristic (ROC) curves were used to evaluate the predictive accuracy of SII and SIRI.

Results: Statistical differences between SII and SIRI in the two groups (P < 0.05) were observed. Multivariate analysis confirmed that SII and SIRI, age and preoperative smoking history were predictors of POD. ROC curve analysis demonstrated that SII and SIRI had considerable predictive power, with AUC values of 0.73 (0.67-0.79) for SII and 0.75 (0.69-0.81) for SIRI.

Conclusion: SII and SIRI were found to be associated with an increased risk of POD in patients undergoing OPCABG, but further research is needed to confirm these findings and determine their independence as risk factors.

目的:术后谵妄(POD)是体外循环冠状动脉搭桥术(OPCABG)后常见的并发症,与严重的发病率相关。本研究旨在评估接受 OPCABG 手术的脑梗塞患者的全身免疫炎症指数(SII)和全身炎症反应指数(SIRI)与术后谵妄(POD)的相关性:围手术期队列研究包括 321 名接受 OPCABG 的患者。根据 POD 发生情况将患者分为两组:谵妄组(113 人)和非谵妄组(208 人)。分析的基线特征包括性别、左心室射血分数(LVEF)、手术时间、高血压、年龄和吸烟史。术前计算 SII 和 SIRI 值,并使用单变量和多变量逻辑回归分析评估其与 POD 的关系。使用接收者操作特征曲线(ROC)评估 SII 和 SIRI 的预测准确性:两组患者的 SII 和 SIRI 存在统计学差异(P 结论:SII 和 SIRI 的预测准确性较高:研究发现,SII 和 SIRI 与接受 OPCABG 患者 POD 风险增加有关,但需要进一步研究来证实这些发现,并确定它们作为风险因素的独立性。
{"title":"Systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) as predictors of postoperative delirium in patients undergoing off-pump coronary artery bypass grafting (OPCABG) with cerebral infarction.","authors":"Bing-Sha Zhao, Wen-Qian Zhai, Min Ren, Zhao Zhang, Jian-Ge Han","doi":"10.1186/s12893-024-02598-7","DOIUrl":"10.1186/s12893-024-02598-7","url":null,"abstract":"<p><strong>Objective: </strong>Postoperative delirium (POD) is a common complication following off-pump coronary artery bypass grafting (OPCABG) and is associated with significant morbidity. This study aims to evaluate the correlation of systemic immune inflammatory index (SII) and systemic inflammatory response index (SIRI) with postoperative delirium (POD) in patients with cerebral infarction undergoing OPCABG.</p><p><strong>Methods: </strong>The perioperative cohort study included 321 patients who underwent OPCABG. Patients were divided into two groups based on the occurrence of POD: the delirium group (n = 113) and the non-delirium group (n = 208). Baseline characteristics, including gender, left ventricular ejection fraction (LVEF), surgery duration, hypertension, age, and smoking history were analyzed. SII and SIRI values were calculated preoperatively, and their association with POD was assessed using univariate and multivariate logistic regression analyses. Receiver operating characteristic (ROC) curves were used to evaluate the predictive accuracy of SII and SIRI.</p><p><strong>Results: </strong>Statistical differences between SII and SIRI in the two groups (P < 0.05) were observed. Multivariate analysis confirmed that SII and SIRI, age and preoperative smoking history were predictors of POD. ROC curve analysis demonstrated that SII and SIRI had considerable predictive power, with AUC values of 0.73 (0.67-0.79) for SII and 0.75 (0.69-0.81) for SIRI.</p><p><strong>Conclusion: </strong>SII and SIRI were found to be associated with an increased risk of POD in patients undergoing OPCABG, but further research is needed to confirm these findings and determine their independence as risk factors.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"338"},"PeriodicalIF":1.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11520795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necrotizing fasciitis: treatment concepts & clinical outcomes - an institutional experience. 坏死性筋膜炎:治疗理念和临床结果--机构经验。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-28 DOI: 10.1186/s12893-024-02638-2
Ajay Raveendranadh, S S Prasad, Vivek Viswanath

Background: A severe infection of the skin and soft tissues, Necrotizing Fasciitis (NF), spreads quickly along the deep fascia. This study aimed to characterize the clinicopathological features, analyze the implicated bacteria's antibiotic sensitivity, evaluate surgical management, and assess the diagnostic accuracy of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score in Necrotizing Soft Tissue Infection (NST).

Methods: This single-center prospective observational study was conducted in the Department of General Surgery, Kasturba Medical College, Manipal, with 171 proven cases of NSTI between 2019 and 2021. Clinico-demographic data and laboratory investigation values were collected at two-time points (at admission and 72 h after admission). Imaging data, LRINEC score, culture results, and antibiotic sensitivity were recorded. Appropriate descriptive and analytical statistics were used for the statistical analysis.

Results: Of the 171 patients, 150 were male (87.7%). The mean age was 57.6 ± 13.1 years. The presenting features in all the cases were pain, swelling, and fever. Diabetes mellitus (DM) is the most common comorbidity. The lower extremities were the most commonly affected sites. Streptococcus pyogenes showed significant growth in 25.41% of the samples. Ceftriaxone sensitivity was seen in 41/141. A score of ≥ 8 was obtained in 118/171 (69%) patients, suggesting a higher severity and significant risk for NSTI. The Area Under the Curve of Receiver Operating characteristic Curve (ROC) for establishing diagnostic accuracy for LRINEC was 0.694. Mortality was significantly higher in the patients with higher LRINEC scores and elevated procalcitonin. The mortality rate was higher in patients who underwent surgery within 12 h.

Conclusion: Necrotizing fasciitis is a soft tissue infection with a high mortality rate. The clinical features and determinants of mortality in patients with NF are highlighted in this study. At the outset, a high index of suspicion was critical. Using prognostic evaluation techniques in daily clinical practice will assist medical professionals in providing adequate on-time care and significantly lowering mortality. The AUC for LRINEC score, although significant, is low. LRINEC score is not to be used to determine whether surgical intervention should be expedited or anticipated. Its role is to aid in prognosticating the outcome of the individual patient. Our study concludes that early extensive surgical debridement remains the single most crucial intervention in patients diagnosed with necrotizing fasciitis (NF), regardless of disease severity and the LRINEC score.

背景:一种严重的皮肤和软组织感染--坏死性筋膜炎(NF)会沿着深筋膜迅速扩散。本研究旨在描述坏死性软组织感染(NST)的临床病理特征、分析相关细菌的抗生素敏感性、评估手术治疗方法,以及评估坏死性筋膜炎实验室风险指标(LRINEC)评分的诊断准确性:这项单中心前瞻性观察研究在马尼帕尔卡斯特尔巴医学院普外科进行,在2019年至2021年期间共收治了171例经证实的NSTI病例。在两个时间点(入院时和入院后 72 小时)收集临床人口学数据和实验室检查值。此外,还记录了影像学数据、LRINEC 评分、培养结果和抗生素敏感性。统计分析采用了适当的描述性和分析性统计方法:在 171 名患者中,有 150 名男性(87.7%)。平均年龄为 57.6 ± 13.1 岁。所有病例的发病特征均为疼痛、肿胀和发热。糖尿病(DM)是最常见的合并症。下肢是最常受影响的部位。化脓性链球菌在 25.41% 的样本中有明显生长。41/141 例样本对头孢曲松敏感。118/171(69%)名患者的评分≥8分,这表明NSTI的严重程度和风险较高。用于确定 LRINEC 诊断准确性的接收者操作特征曲线(ROC)曲线下面积为 0.694。LRINEC 评分较高且降钙素原升高的患者死亡率明显较高。12小时内接受手术的患者死亡率更高:结论:坏死性筋膜炎是一种死亡率很高的软组织感染。本研究强调了坏死性筋膜炎患者的临床特征和死亡率的决定因素。首先,高度怀疑至关重要。在日常临床实践中使用预后评估技术将有助于医务人员及时提供适当的护理,并显著降低死亡率。LRINEC 评分的 AUC 虽然显著,但却很低。LRINEC 评分不能用于确定是否应加快或预期手术干预。它的作用是帮助预测个体患者的预后。我们的研究得出结论,对于确诊为坏死性筋膜炎(NF)的患者,无论疾病严重程度和 LRINEC 评分如何,早期大面积手术清创仍是最关键的干预措施。
{"title":"Necrotizing fasciitis: treatment concepts & clinical outcomes - an institutional experience.","authors":"Ajay Raveendranadh, S S Prasad, Vivek Viswanath","doi":"10.1186/s12893-024-02638-2","DOIUrl":"10.1186/s12893-024-02638-2","url":null,"abstract":"<p><strong>Background: </strong>A severe infection of the skin and soft tissues, Necrotizing Fasciitis (NF), spreads quickly along the deep fascia. This study aimed to characterize the clinicopathological features, analyze the implicated bacteria's antibiotic sensitivity, evaluate surgical management, and assess the diagnostic accuracy of the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score in Necrotizing Soft Tissue Infection (NST).</p><p><strong>Methods: </strong>This single-center prospective observational study was conducted in the Department of General Surgery, Kasturba Medical College, Manipal, with 171 proven cases of NSTI between 2019 and 2021. Clinico-demographic data and laboratory investigation values were collected at two-time points (at admission and 72 h after admission). Imaging data, LRINEC score, culture results, and antibiotic sensitivity were recorded. Appropriate descriptive and analytical statistics were used for the statistical analysis.</p><p><strong>Results: </strong>Of the 171 patients, 150 were male (87.7%). The mean age was 57.6 ± 13.1 years. The presenting features in all the cases were pain, swelling, and fever. Diabetes mellitus (DM) is the most common comorbidity. The lower extremities were the most commonly affected sites. Streptococcus pyogenes showed significant growth in 25.41% of the samples. Ceftriaxone sensitivity was seen in 41/141. A score of ≥ 8 was obtained in 118/171 (69%) patients, suggesting a higher severity and significant risk for NSTI. The Area Under the Curve of Receiver Operating characteristic Curve (ROC) for establishing diagnostic accuracy for LRINEC was 0.694. Mortality was significantly higher in the patients with higher LRINEC scores and elevated procalcitonin. The mortality rate was higher in patients who underwent surgery within 12 h.</p><p><strong>Conclusion: </strong>Necrotizing fasciitis is a soft tissue infection with a high mortality rate. The clinical features and determinants of mortality in patients with NF are highlighted in this study. At the outset, a high index of suspicion was critical. Using prognostic evaluation techniques in daily clinical practice will assist medical professionals in providing adequate on-time care and significantly lowering mortality. The AUC for LRINEC score, although significant, is low. LRINEC score is not to be used to determine whether surgical intervention should be expedited or anticipated. Its role is to aid in prognosticating the outcome of the individual patient. Our study concludes that early extensive surgical debridement remains the single most crucial intervention in patients diagnosed with necrotizing fasciitis (NF), regardless of disease severity and the LRINEC score.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"336"},"PeriodicalIF":1.6,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Cardiac overload resolved by resection of a large plexiform neurofibroma on both the buttocks and upper posterior thighs in a patient with neurofibromatosis type I: a case report. 更正:一例神经纤维瘤病 I 型患者臀部和大腿后上部的巨大丛状神经纤维瘤切除术缓解了心脏负荷过重。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-26 DOI: 10.1186/s12893-024-02591-0
Taro Mikami, Yuki Honma-Koretsune, Yui Tsunoda, Shintaro Kagimoto, Yuichiro Yabuki, Jiro Maegawa, Miki Terauchi, Shintaro Nawata, Hiroyuki Kamide, Yoshinobu Ishiwata, Tabito Kino, Teruyasu Sugano
{"title":"Correction: Cardiac overload resolved by resection of a large plexiform neurofibroma on both the buttocks and upper posterior thighs in a patient with neurofibromatosis type I: a case report.","authors":"Taro Mikami, Yuki Honma-Koretsune, Yui Tsunoda, Shintaro Kagimoto, Yuichiro Yabuki, Jiro Maegawa, Miki Terauchi, Shintaro Nawata, Hiroyuki Kamide, Yoshinobu Ishiwata, Tabito Kino, Teruyasu Sugano","doi":"10.1186/s12893-024-02591-0","DOIUrl":"10.1186/s12893-024-02591-0","url":null,"abstract":"","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"335"},"PeriodicalIF":1.6,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of prophylactic infusion of norepinephrine on the prevention of hypotension during vertebroplasty: a randomized clinical trial. 预防性输注去甲肾上腺素对预防椎体成形术中低血压的影响:随机临床试验。
IF 1.6 3区 医学 Q2 SURGERY Pub Date : 2024-10-26 DOI: 10.1186/s12893-024-02640-8
Qun Fu, Shengan Liu, Yunqian Sun, Ming Jiang, Dongliang Tang, Yang Jiao

Background: Transient hypotension is a common occurrence during the implantation of bone cement. This placebo-controlled randomized clinical trial study investigated the effect of prophylactic infusion of norepinephrine on the incidence of hypotension in senior patients who underwent vertebroplasty.

Methods: The trial recruited patients who were greater than or equal to 65 years of age, had an American Society of Anesthesiologist physical status classification of I to III, and underwent vertebroplasty from August 2020 to August 2021 at the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine in China. The patients were randomly grouped according to whether they received either a norepinephrine infusion of 0.05 µg/kg/min or an equivalent volume of saline 10 min before implantation of bone cement. Intraoperative hemodynamics were monitored continuously by the MostCare system at the following 7 time points: 10 min before implantation of bone cement and immediately, 30 s, 1, 3, 5, and 10 min after implantation of bone cement. We also recorded the number of hypotensive episodes and the total number of vasopressors after implantation of bone cement. Multivariable logistic regression was used to assess the risk factors associated with hypotension after implantation of bone cement.

Results: A total of 63 patients were randomized to the control group (n = 31; median [IQR] age, 74 [69-79] years) and the norepinephrine group (n = 32; median [IQR] age, 75 [71-79] years). The incidence of hypotension in the norepinephrine group was significantly lower than that in the control group after implantation of bone cement (12.5% vs. 45.2%; relative risk [RR], 3.61 [95% CI, 1.13-15.07]; P = 0.005). Moreover, the median (IQR) number of hypotensive episodes (0 [0-0] vs. 0 [0-2]; P = 0.005) and the total number of vasopressors (0 [0-0] vs. 0 [0-1]; P = 0.004) in the norepinephrine group were significantly lower than those in the control group. Furthermore, compared with the baseline, the MAP significantly decreased at 1 min (P = 0.007) and 3 min (P < 0.001) after bone cement implantation in the control group. However, the MAP at 3 min in the norepinephrine group was significantly higher than that in the control group (P < 0.001). The incidence of complications was not different between the groups. In multivariable logistic regression, the FRAIL score (OR, 2.29; 95% CI, 1.21-4.31) was identified as a risk factor associated with hypotension.

Conclusion: Prophylactic infusion of norepinephrine before bone cement implantation can stabilize hemodynamics and reduce the incidence of hypotension after implantation of bone cement.

背景:一过性低血压是骨水泥植入过程中的常见病。这项安慰剂对照随机临床试验研究探讨了预防性输注去甲肾上腺素对高龄椎体成形术患者低血压发生率的影响:该试验招募了2020年8月至2021年8月期间在中国南京中医药大学附属中西医结合医院接受椎体成形术的年龄大于或等于65岁、美国麻醉医师协会身体状况分级为I至III级的患者。根据患者是否在植入骨水泥前 10 分钟输注 0.05 µg/kg/min 的去甲肾上腺素或等量生理盐水进行随机分组。在以下 7 个时间点,MostCare 系统对术中血流动力学进行连续监测:骨水泥植入前 10 分钟、骨水泥植入后立即、30 秒、1、3、5 和 10 分钟。我们还记录了骨水泥植入后低血压发作的次数和血管加压的总次数。采用多变量逻辑回归评估与骨水泥植入后低血压相关的风险因素:共有63名患者被随机分为对照组(n = 31;中位数[IQR]年龄,74 [69-79]岁)和去甲肾上腺素组(n = 32;中位数[IQR]年龄,75 [71-79]岁)。植入骨水泥后,去甲肾上腺素组的低血压发生率明显低于对照组(12.5% 对 45.2%;相对风险 [RR],3.61 [95% CI,1.13-15.07];P = 0.005)。此外,去甲肾上腺素组的低血压发作次数中位数(IQR)(0 [0-0] vs. 0 [0-2];P = 0.005)和使用血管加压药的总次数(0 [0-0] vs. 0 [0-1];P = 0.004)均显著低于对照组。此外,与基线相比,去甲肾上腺素组的 MAP 在 1 分钟(P = 0.007)和 3 分钟(P = 0.005)时明显下降(P = 0.006):骨水泥植入前预防性输注去甲肾上腺素可稳定血流动力学,降低骨水泥植入后低血压的发生率。
{"title":"Effect of prophylactic infusion of norepinephrine on the prevention of hypotension during vertebroplasty: a randomized clinical trial.","authors":"Qun Fu, Shengan Liu, Yunqian Sun, Ming Jiang, Dongliang Tang, Yang Jiao","doi":"10.1186/s12893-024-02640-8","DOIUrl":"10.1186/s12893-024-02640-8","url":null,"abstract":"<p><strong>Background: </strong>Transient hypotension is a common occurrence during the implantation of bone cement. This placebo-controlled randomized clinical trial study investigated the effect of prophylactic infusion of norepinephrine on the incidence of hypotension in senior patients who underwent vertebroplasty.</p><p><strong>Methods: </strong>The trial recruited patients who were greater than or equal to 65 years of age, had an American Society of Anesthesiologist physical status classification of I to III, and underwent vertebroplasty from August 2020 to August 2021 at the Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine in China. The patients were randomly grouped according to whether they received either a norepinephrine infusion of 0.05 µg/kg/min or an equivalent volume of saline 10 min before implantation of bone cement. Intraoperative hemodynamics were monitored continuously by the MostCare system at the following 7 time points: 10 min before implantation of bone cement and immediately, 30 s, 1, 3, 5, and 10 min after implantation of bone cement. We also recorded the number of hypotensive episodes and the total number of vasopressors after implantation of bone cement. Multivariable logistic regression was used to assess the risk factors associated with hypotension after implantation of bone cement.</p><p><strong>Results: </strong>A total of 63 patients were randomized to the control group (n = 31; median [IQR] age, 74 [69-79] years) and the norepinephrine group (n = 32; median [IQR] age, 75 [71-79] years). The incidence of hypotension in the norepinephrine group was significantly lower than that in the control group after implantation of bone cement (12.5% vs. 45.2%; relative risk [RR], 3.61 [95% CI, 1.13-15.07]; P = 0.005). Moreover, the median (IQR) number of hypotensive episodes (0 [0-0] vs. 0 [0-2]; P = 0.005) and the total number of vasopressors (0 [0-0] vs. 0 [0-1]; P = 0.004) in the norepinephrine group were significantly lower than those in the control group. Furthermore, compared with the baseline, the MAP significantly decreased at 1 min (P = 0.007) and 3 min (P < 0.001) after bone cement implantation in the control group. However, the MAP at 3 min in the norepinephrine group was significantly higher than that in the control group (P < 0.001). The incidence of complications was not different between the groups. In multivariable logistic regression, the FRAIL score (OR, 2.29; 95% CI, 1.21-4.31) was identified as a risk factor associated with hypotension.</p><p><strong>Conclusion: </strong>Prophylactic infusion of norepinephrine before bone cement implantation can stabilize hemodynamics and reduce the incidence of hypotension after implantation of bone cement.</p>","PeriodicalId":49229,"journal":{"name":"BMC Surgery","volume":"24 1","pages":"333"},"PeriodicalIF":1.6,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11515096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142511451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1